25 , 26 On the other hand, it has been shown that the GPER pathway may be involved in the aggressive behavior of breast tumors by regulation of expression of the aromatase enzyme, after GPER inhibition in tamoxifen-resistant MCF-7 cells. Here, CYP19A1 is linked to breast neoplasm.